The Ubiquitin Ligase RBX2/SAG Regulates Mitochondrial Ubiquitination and Mitophagy.

heart failure mitochondria mitophagy protein kinases ubiquitination

Journal

Circulation research
ISSN: 1524-4571
Titre abrégé: Circ Res
Pays: United States
ID NLM: 0047103

Informations de publication

Date de publication:
14 Jun 2024
Historique:
medline: 14 6 2024
pubmed: 14 6 2024
entrez: 14 6 2024
Statut: aheadofprint

Résumé

Clearance of damaged mitochondria via mitophagy is crucial for cellular homeostasis. Apart from Parkin, little is known about additional Ub (ubiquitin) ligases that mediate mitochondrial ubiquitination and turnover, particularly in highly metabolically active organs such as the heart. In this study, we have combined in silico analysis and biochemical assay to identify CRL (cullin-RING ligase) 5 as a mitochondrial Ub ligase. We generated cardiomyocytes and mice lacking RBX2 (RING-box protein 2; also known as SAG [sensitive to apoptosis gene]), a catalytic subunit of CRL5, to understand the effects of RBX2 depletion on mitochondrial ubiquitination, mitophagy, and cardiac function. We also performed proteomics analysis and RNA-sequencing analysis to define the impact of loss of RBX2 on the proteome and transcriptome. RBX2 and CUL (cullin) 5, 2 core components of CRL5, localize to mitochondria. Depletion of RBX2 inhibited mitochondrial ubiquitination and turnover, impaired mitochondrial membrane potential and respiration, increased cardiomyocyte cell death, and has a global impact on the mitochondrial proteome. In vivo, deletion of the These findings identify RBX2-CRL5 as a mitochondrial Ub ligase that regulates mitophagy and cardiac homeostasis in a Parkin-independent, PINK1-dependent manner.

Sections du résumé

BACKGROUND UNASSIGNED
Clearance of damaged mitochondria via mitophagy is crucial for cellular homeostasis. Apart from Parkin, little is known about additional Ub (ubiquitin) ligases that mediate mitochondrial ubiquitination and turnover, particularly in highly metabolically active organs such as the heart.
METHODS UNASSIGNED
In this study, we have combined in silico analysis and biochemical assay to identify CRL (cullin-RING ligase) 5 as a mitochondrial Ub ligase. We generated cardiomyocytes and mice lacking RBX2 (RING-box protein 2; also known as SAG [sensitive to apoptosis gene]), a catalytic subunit of CRL5, to understand the effects of RBX2 depletion on mitochondrial ubiquitination, mitophagy, and cardiac function. We also performed proteomics analysis and RNA-sequencing analysis to define the impact of loss of RBX2 on the proteome and transcriptome.
RESULTS UNASSIGNED
RBX2 and CUL (cullin) 5, 2 core components of CRL5, localize to mitochondria. Depletion of RBX2 inhibited mitochondrial ubiquitination and turnover, impaired mitochondrial membrane potential and respiration, increased cardiomyocyte cell death, and has a global impact on the mitochondrial proteome. In vivo, deletion of the
CONCLUSIONS UNASSIGNED
These findings identify RBX2-CRL5 as a mitochondrial Ub ligase that regulates mitophagy and cardiac homeostasis in a Parkin-independent, PINK1-dependent manner.

Identifiants

pubmed: 38873758
doi: 10.1161/CIRCRESAHA.124.324285
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Wenjuan Wang (W)

Vascular Biology Center, Medical College of Georgia, Augusta University. (W.W., E.L., J. Zou, C.Q., J.A., Y.W., M.S.I., N.L.W., D.J.F., J. Li, H.S.).
Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation, State Key Laboratory of Respiratory Disease, School of Basic Medical Sciences, Guangzhou Medical University, China (W.W., J. Liu).

Ermin Li (E)

Vascular Biology Center, Medical College of Georgia, Augusta University. (W.W., E.L., J. Zou, C.Q., J.A., Y.W., M.S.I., N.L.W., D.J.F., J. Li, H.S.).

Jianqiu Zou (J)

Vascular Biology Center, Medical College of Georgia, Augusta University. (W.W., E.L., J. Zou, C.Q., J.A., Y.W., M.S.I., N.L.W., D.J.F., J. Li, H.S.).

Chen Qu (C)

Vascular Biology Center, Medical College of Georgia, Augusta University. (W.W., E.L., J. Zou, C.Q., J.A., Y.W., M.S.I., N.L.W., D.J.F., J. Li, H.S.).

Juan Ayala (J)

Vascular Biology Center, Medical College of Georgia, Augusta University. (W.W., E.L., J. Zou, C.Q., J.A., Y.W., M.S.I., N.L.W., D.J.F., J. Li, H.S.).

Yuan Wen (Y)

Vascular Biology Center, Medical College of Georgia, Augusta University. (W.W., E.L., J. Zou, C.Q., J.A., Y.W., M.S.I., N.L.W., D.J.F., J. Li, H.S.).
Department of Cardiology, The First Affiliated Hospital of Nanchang University, Jiangxi, China (Y.W.).

Md Sadikul Islam (MS)

Vascular Biology Center, Medical College of Georgia, Augusta University. (W.W., E.L., J. Zou, C.Q., J.A., Y.W., M.S.I., N.L.W., D.J.F., J. Li, H.S.).

Neal L Weintraub (NL)

Vascular Biology Center, Medical College of Georgia, Augusta University. (W.W., E.L., J. Zou, C.Q., J.A., Y.W., M.S.I., N.L.W., D.J.F., J. Li, H.S.).
Department of Medicine, Medical College of Georgia, Augusta University. (N.L.W., J. Li).

David J Fulton (DJ)

Vascular Biology Center, Medical College of Georgia, Augusta University. (W.W., E.L., J. Zou, C.Q., J.A., Y.W., M.S.I., N.L.W., D.J.F., J. Li, H.S.).

Qiangrong Liang (Q)

Department of Biomedical Sciences, College of Osteopathic Medicine, New York Institute of Technology, Old Westbury (Q.L.).

Jiliang Zhou (J)

Department of Pharmacology and Toxicology, Medical College of Georgia, Augusta University. (J. Zhou, H.S.).

Jinbao Liu (J)

Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation, State Key Laboratory of Respiratory Disease, School of Basic Medical Sciences, Guangzhou Medical University, China (W.W., J. Liu).

Jie Li (J)

Vascular Biology Center, Medical College of Georgia, Augusta University. (W.W., E.L., J. Zou, C.Q., J.A., Y.W., M.S.I., N.L.W., D.J.F., J. Li, H.S.).
Department of Medicine, Medical College of Georgia, Augusta University. (N.L.W., J. Li).

Yi Sun (Y)

Cancer Institute of the Second Affiliated Hospital and Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou, China (Y.S.).

Huabo Su (H)

Vascular Biology Center, Medical College of Georgia, Augusta University. (W.W., E.L., J. Zou, C.Q., J.A., Y.W., M.S.I., N.L.W., D.J.F., J. Li, H.S.).
Department of Pharmacology and Toxicology, Medical College of Georgia, Augusta University. (J. Zhou, H.S.).

Classifications MeSH